Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (171-180 of 494) with videos related to

Pageof 50
Sort By:
Human Pathology|July 27, 2010
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancersAndreas H Marx, Eike C Burandt, Matthias Choschzick, et al.
Cancer Research|March 16, 2013
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancerLia Burkhardt, Sarah Fuchs, Antje Krohn, et al.
Urologic Oncology|May 23, 2022
Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16Maximilian Lennartz, Henrietta Csomós, Christian Bernreuther, et al.
BJU International|March 16, 2017
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimensStefan Steurer, Sebastian Dwertmann Rico, Ronald Simon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2014
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletionsKatharina Grupp, Julia Wilking, Kristina Prien, et al.
European Urology|May 27, 2008
Molecular cancer phenotype in normal prostate tissueThorsten Schlomm, Olaf J C Hellwinkel, Andreas Buness, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancerThorsten Schlomm, Patrick Kirstein, Liv Iwers, et al.
Oncology Letters|March 22, 2016
High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancerPatrick Lebok, Melike Öztürk, Uwe Heilenkötter, et al.
The Journal of Trauma and Acute Care Surgery|March 21, 2013
Vulnerable roadway users struck by motor vehicles at the center of the safest, large US cityLinda A Dultz, George Foltin, Ronald Simon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2012
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancerTobias J Grob, Tobias Hoenig, Till S Clauditz, et al.
Pageof 50

Showing results (171-180 of 494) with videos related to

Sort By:
Pageof 50
Human Pathology|July 27, 2010
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancersAndreas H Marx, Eike C Burandt, Matthias Choschzick, et al.
Cancer Research|March 16, 2013
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancerLia Burkhardt, Sarah Fuchs, Antje Krohn, et al.
Urologic Oncology|May 23, 2022
Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16Maximilian Lennartz, Henrietta Csomós, Christian Bernreuther, et al.
BJU International|March 16, 2017
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimensStefan Steurer, Sebastian Dwertmann Rico, Ronald Simon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2014
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletionsKatharina Grupp, Julia Wilking, Kristina Prien, et al.
European Urology|May 27, 2008
Molecular cancer phenotype in normal prostate tissueThorsten Schlomm, Olaf J C Hellwinkel, Andreas Buness, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancerThorsten Schlomm, Patrick Kirstein, Liv Iwers, et al.
Oncology Letters|March 22, 2016
High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancerPatrick Lebok, Melike Öztürk, Uwe Heilenkötter, et al.
The Journal of Trauma and Acute Care Surgery|March 21, 2013
Vulnerable roadway users struck by motor vehicles at the center of the safest, large US cityLinda A Dultz, George Foltin, Ronald Simon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2012
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancerTobias J Grob, Tobias Hoenig, Till S Clauditz, et al.
Pageof 50